Article info

Download PDFPDF
Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy
  1. Dr S Flores Moreno, Andalusian Agency for Health Technology Assessment, Zafra street, n°1 Seville, 41006 Spain; sandra.flores.sspa{at}juntadeandalucia.es
View Full Text

Citation

Moreno SF, Paloma JB
Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy

Publication history

  • Accepted March 4, 2008
  • First published June 3, 2008.
Online issue publication 
June 03, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.